Abstract:The guanosine triphosphatase-activating protein RLIP76 is overexpressed in many malignant tumor cells, but it is unclear if RLIP76 overexpression contributes to the high proliferative potential of glioma cells. We demonstrate that RLIP76 messenger RNA and protein expression are positively correlated with glioma grade and that higher RLIP76 expression correlates with shorter patient survival. Immunohistochemical staining revealed that RLIP76 expression was positively correlated with the expression of Ki-67, a biomarker for cell proliferation. Inhibition of RLIP76 expression in U87 and U251 glioma cell lines by stable transfection of a targeted siRNA suppressed anchorage-independent growth and enhanced apoptosis in vitro. Conversely, overexpression of RLIP76 in SW1088 and U251 cell lines enhanced proliferation and reduced apoptosis. Inhibition of RLIP76 in U251 cells also significantly suppressed tumorigenicity and induced apoptosis in an endotopic xenograft mouse model. Moreover, we demonstrate that knockdown of RLIP76 increases apoptosis in different human gliomas independently of p53 status. In addition, a constitutively active Rac1 reversed both the suppression of proliferation and the promotion of apoptosis induced by the RLIP76-targeted siRNA, indicating that RLIP76 is an upstream activator of Rac1. Rac1-mediated suppression of apoptosis and promotion of proliferation were dependent on intact c-jun N-terminal kinase (JNK) signaling. Furthermore, we demonstrate that RLIP76 promotes proliferation and suppresses glioma cell apoptosis through a mechanism independent of Rho-selective GTPase-activating protein. Instead, we found that the adenosine triphosphatase function of Rlip76 modulates Rac1 activity by regulating Rac1 protein ubiquitylation and degradation. These data demonstrate that RLIP76 may suppress apoptosis and promote the proliferation of glioma cells by direct adenosine triphosphate-dependent xenobiotic transport and by activating the Rac1-JNK signaling pathway. Inhibition of RLIP76 signaling is a potential treatment for malignant glioma.

PRL1 Promotes Glioblastoma Invasion and Tumorigenesis <i>via</i> Activating USP36-Mediated Snail2 Deubiquitination

PRL1 Promotes Glioblastoma Invasion and Tumorigenesis via Activating USP36-Mediated Snail2 Deubiquitination

RLIP76 is Overexpressed in Human Glioblastomas and is Required for Proliferation, Tumorigenesis and Suppression of Apoptosis.

PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways

The phosphatase of regenerating liver-3 protein (PRL-3) promotes glioma cell invasiveness by interacting with β3 –tubulin

Ubiquitin-Specific Protease 3 Promotes Glioblastoma Cell Invasion and Epithelial–Mesenchymal Transition Via Stabilizing Snail

Increased RLIP76 Expression in IDH1 Wild‑type Glioblastoma Multiforme is Associated with Worse Prognosis

Overexpression of RLIP76 Required for Proliferation in Meningioma is Associated with Recurrence.

PHLDA1 promotes glioblastoma cell growth via sustaining the activation state of Ras

PDRG1 promotes the proliferation and migration of GBM cells by the MEK/ERK/CD44 pathway

NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K/Akt activation

Identification of PDLIM1 as a glioblastoma stem cell marker driving tumorigenesis and chemoresistance

Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility.

PLAGL2 promotes the proliferation and migration of gastric cancer cells via USP37-mediated deubiquitination of Snail1

PHLDA1 Promotes Glioblastoma Oncogenesis via Ras/Mek/Erk Signaling Pathway

LZTR1 inactivation promotes MAPK/ ERK pathway activation in glioblastoma by stabilizing oncoprotein RIT1

PRL-3 Promotes the Malignant Progression of Melanoma Via Triggering Dephosphorylation and Cytoplasmic Localization of NHERF1

PRL1 and PRL3 promote macropinocytosis via its lipid phosphatase activity

PRL-3 Promotes Gastric Cancer Migration and Invasion Through a NF-κB-HIF-1α-miR-210 Axis.

The LGMN pseudogene promotes tumor progression by acting as a miR-495-3p sponge in glioblastoma

Expression and Tumor-Promoting Effect of Tyrosine Phosphatase Receptor Type N (PTPRN) in Human Glioma